Why the study?
Critical flicker fusion frequency (CFF) could aid in the early detection of retinal dysfunction and optic neuropathic changes, but its variation with glycemic control in T2DM required comparison.
Does poor glycemic control reduce critical flicker fusion frequency in patients with Type 2 diabetes mellitus?
Does poor glycemic control reduce critical flicker fusion frequency in patients with Type 2 diabetes mellitus?
Answers are grounded in this paper and cite their sources.
Poor glycemic control in Type 2 diabetes mellitus is associated with significantly lower critical flicker fusion frequency, suggesting early retinal or optic nerve dysfunction.
Introduction: India has a large number of diabetic patients and there is a steep rise in the incidence ofdiabetes in the last decade. Diabetic control is categorized as poor control (HbA1c levels above 7%) andgood control (HbA1c levels below 7%). Critical flicker fusion frequency (CFF) is a non-invasive test, whichcould help early detection of retinal dysfunction and optic neuropathic changes in Type 2 diabetes mellitus(T2DM).Objective: To compare the CFF betweenGroup 1: T2DM (HbA1c < 7%).Group 2: T2DM (HbA1c >7%).Methodology: Sixty diagnosed T2DM patients were the subjects in this study. Thirty patients had theirHbA1c < 7 g% and 30 >7 g%. The patients were recruited from Medicine department, Rajarajeswari MedicalCollege and Hospital. CFF was measured using an in-house built apparatus. CFF values were noted and thenanalyzed.Results and Discussion: The mean CFF in group I and the group II patients were 30.17+ 4.69 Hz and26.32+ 6.70 Hz, respectively. This was highly significant (P = 0.012). The significantly lower CFF in thepoorly controlled group II diabetics can be attributed to poorglycemic control in that group.
No takes yet. Share an insight, caveat, or question.
Gopi Kumar (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: